Engineering the future of heart attack care.

We’re building ultrasound catheters for rapid clot disruption and
microvascular protection during PCI.

Engineering the future of heart attack care

We’re building ultrasound catheters for rapid clot disruption and
microvascular protection during PCI.

When there's no solution

1 out of 2 heart attack patients still develops microvascular obstruction (MVO), blockage in the heart’s smallest blood vessels — even after timely treatment. MVO remains a major driver of poor recovery, heart failure, and long-term mortality after heart attack treatment.

A first-in-class ultrasound catheter solution for PCI

We’re building a new approach to rapid clot disruption and microvascular protection during heart attack treatment.

Dual Cathether Design

First PCI-compatible system to combine ultrafast acoustic thrombus disruption, local fragment capture, and closed-loop safety control without lytic drugs

Know More

Product Suite

A user-friendly CardioCare suite that fits seamlessly into the existing PCI workflow.

Know More

A first-in-class ultrasound catheter solution for PCI

We’re building a new approach to rapid clot disruption and microvascular protection during heart attack treatment.

Dual Cathether Design

First PCI-compatible system to combine ultrafast acoustic thrombus disruption, local fragment capture, and closed-loop safety control without lytic drugs

Know More

Product Suite

A user-friendly CardioCare suite that fits seamlessly into the existing PCI workflow.

Know More

Take the next step forward

Partner With Us

At SonoRobotics, we are developing catheter-based ultrasound technology designed for rapid thrombus dissolution, active clot management, and seamless integration into interventional workflows.

Get Connected Now

Years of Research

Patents & Pending patent

Engineering the future of heart attack care.

Engineering the future of heart attack care.

We’re building ultrasound catheters for rapid clot disruption and microvascular protection during PCI.

Engineering the future of heart attack care

Engineering the future of heart attack care

Engineering the future of heart attack care

Engineering the future of heart attack care

We’re building ultrasound catheters for rapid clot disruption and microvascular protection during PCI.

When there's no solution

When there's no solution

1 out of 2 heart attack patients still develops microvascular obstruction (MVO), blockage in the heart’s smallest blood vessels — even after timely treatment. MVO remains a major driver of poor recovery, heart failure, and long-term mortality after heart attack treatment.

A first-in-class ultrasound catheter solution for PCI

We’re building a new approach to rapid clot disruption and microvascular protection during heart attack treatment.

Dual Cathether Design

Product Suite

A first-in-class ultrasound catheter solution for PCI

We’re building a new approach to rapid clot disruption and microvascular protection during heart attack treatment.

Dual Cathether Design

Product Suite

Take the next step forward

We’re building ultrasound catheters for rapid clot disruption and
microvascular protection during PCI.

We’re building ultrasound catheters for rapid clot disruption and
microvascular protection during PCI.